SXG-16903-57139
4 vaccinations
6 coded responses
43 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 787 / TX
- Registered
- 2021-02-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
F5U-15894-79480
Child or adolescent in my care · Female · 2022-06-24
TXF-62896-67773
Child or adolescent in my care · Female · 2022-09-20
Timeline
-
2021-02-23
Registered in v-safe
-
2021-02-23
Dose 1 — Pfizer-BioNTech
- 2021-02-23
-
2021-02-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-02-28
- 2021-03-02
- 2021-03-09
-
2021-03-16
Dose 2 — Pfizer-BioNTech
- 2021-03-16
-
2021-03-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-18
Survey response — days 1–6 daily, dose 2MedDRA: Hyperacusis, Photophobia — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sensitivity to light and soundMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-19
- 2021-03-20
-
2021-03-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-03-25
- 2021-03-30
- 2021-04-06
- 2021-04-15
- 2021-04-20
- 2021-04-27
- 2021-09-14
-
2021-12-22
Dose 3 — Pfizer-BioNTech
- 2021-12-22
-
2021-12-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-25
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-26
- 2021-12-27
- 2021-12-29
- 2022-01-05
- 2022-01-13
- 2022-01-21
- 2022-01-30
-
2022-03-23
Survey response — 3 months, dose 3MedDRA: Delivery, Pre-eclampsia, Urinary tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pre-eclampsia and delivery of baby, UTIsMedDRA releases: 2024-11 · check-in free text available
- 2022-06-22
-
2022-09-30
Dose 4 — Moderna
-
2022-10-01
Survey response — days 1–6 daily, dose 4MedDRA: Vertigo — Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Head spinningMedDRA releases: 2024-11 · check-in free text available
-
2022-10-03
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-04
-
2022-10-05
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2022-10-07
- 2022-10-21
-
2022-10-30
Survey response — day 28, dose 4MedDRA: Influenza — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Likely fluMedDRA releases: 2024-11 · check-in free text available
- 2022-11-05
-
2022-11-11
Survey response — day 42, dose 4MedDRA: Influenza, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Flu and upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-30
Survey response — 3 months, dose 4MedDRA: Ageusia, Anosmia, Arthralgia, Cough, Fatigue, Headache, Myalgia, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tested positive for Covid-19 on 11/22/2022 and experienced moderate symptoms including joint pain, muscle aches, fatigue, congestion, cough, headache, and loss of taste and smell for about 10 days.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-23 | Pfizer-BioNTech | |
| 2 | 2021-03-16 | Pfizer-BioNTech | |
| 3 | 2021-12-22 | Pfizer-BioNTech | No |
| 4 | 2022-09-30 | Moderna | No |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Sensitivity to light and sound
Release 11 — 3 months, dose 3
Symptoms: Pre-eclampsia and delivery of baby, UTIs
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Head spinning
Release 12 — day 28, dose 4
Symptoms: Likely flu
Release 12 — day 42, dose 4
Symptoms: Flu and upper respiratory infection
Release 12 — 3 months, dose 4
Symptoms: Tested positive for Covid-19 on 11/22/2022 and experienced moderate symptoms including joint pain, muscle aches, fatigue, congestion, cough, headache, and loss of taste and smell for about 10 days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
| SRO | Hyperacusis | ✓ | ✓ | ✓ |
| SRO | Photophobia | ✓ | ✓ | ✓ |
| SRO | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release